ALMS
ALMS
NASDAQ · Pharmaceuticals

Alumis Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$24.81
+1.74 (+7.54%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -1.2% upside
Low Target $15.34
Average Target $24.51
High Target $36.47
Current Price $24.81
Current
$24.81
Target
$24.51
$15.34 $24.51 avg $36.47
Scenario Analysis
Bear Case
$15.34
-38.2%
Low target
Base Case
$24.51
-1.2%
Avg target
Bull Case
$36.47
+47.0%
High target
Risk/Reward
1.2x
Balanced
Price in Context
52-Week High
$30.60
-18.9% from high
52-Week Low
$2.76
+798.9% from low
50-Day SMA
$19.51
+27.2% vs SMA
200-Day SMA
$8.26
+200.4% vs SMA
RSI (14)
60.5
Neutral
Target vs 52W High
$24.51
-19.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%